Equities research analysts expect that Omega Healthcare Investors Inc (NYSE:OHI) will announce sales of $219.91 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Omega Healthcare Investors’ earnings, with the lowest sales estimate coming in at $215.24 million and the highest estimate coming in at $222.40 million. Omega Healthcare Investors posted sales of $219.64 million in the same quarter last year, which suggests a positive year-over-year growth rate of 0.1%. The firm is scheduled to report its next earnings results on Monday, October 29th.
According to Zacks, analysts expect that Omega Healthcare Investors will report full-year sales of $870.34 million for the current financial year, with estimates ranging from $822.00 million to $887.10 million. For the next fiscal year, analysts expect that the firm will post sales of $889.85 million, with estimates ranging from $811.00 million to $917.50 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Omega Healthcare Investors.
Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Friday, August 3rd. The real estate investment trust reported $0.75 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.02. The company had revenue of $192.85 million for the quarter, compared to the consensus estimate of $200.30 million. Omega Healthcare Investors had a return on equity of 2.49% and a net margin of 10.61%. The firm’s revenue was down .6% compared to the same quarter last year. During the same period last year, the business posted $0.87 earnings per share.
Several equities research analysts have recently issued reports on OHI shares. MED started coverage on Omega Healthcare Investors in a research report on Tuesday, October 2nd. They issued a “neutral” rating and a $31.00 price target on the stock. They noted that the move was a valuation call. Zacks Investment Research raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 16th. Mitsubishi UFJ Financial Group reaffirmed a “neutral” rating on shares of Omega Healthcare Investors in a research report on Tuesday, October 2nd. Stifel Nicolaus raised their price target on Omega Healthcare Investors from $27.00 to $30.00 and gave the company a “hold” rating in a research report on Tuesday, August 7th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $34.00 price target on shares of Omega Healthcare Investors in a research report on Monday, August 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Omega Healthcare Investors has a consensus rating of “Hold” and an average target price of $30.87.
A number of hedge funds have recently added to or reduced their stakes in the stock. Selective Wealth Management acquired a new stake in Omega Healthcare Investors during the third quarter worth about $613,000. United Capital Management of KS Inc. acquired a new stake in Omega Healthcare Investors during the third quarter worth about $361,000. ACG Wealth acquired a new stake in Omega Healthcare Investors during the third quarter worth about $254,000. Northern Trust Corp grew its position in Omega Healthcare Investors by 4.4% during the second quarter. Northern Trust Corp now owns 2,976,392 shares of the real estate investment trust’s stock worth $92,268,000 after buying an additional 125,832 shares in the last quarter. Finally, Truvestments Capital LLC acquired a new stake in Omega Healthcare Investors during the second quarter worth about $909,000. 72.25% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:OHI traded down $0.14 during midday trading on Monday, hitting $31.98. The company’s stock had a trading volume of 1,717,362 shares, compared to its average volume of 1,901,612. The company has a market cap of $6.57 billion, a P/E ratio of 9.69, a P/E/G ratio of 5.51 and a beta of 0.29. Omega Healthcare Investors has a fifty-two week low of $24.90 and a fifty-two week high of $33.63. The company has a debt-to-equity ratio of 1.15, a quick ratio of 4.03 and a current ratio of 4.03.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: Relative Strength Index
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.